xRead - Swallowing Disorders in the Adult Patient (October 2024)

10976817, 2023, 4, Downloaded from https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1002/ohn.302, Wiley Online Library on [08/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

589

Kuhn et al.

(EAT ‐ RT): structured therapy model to facilitate con tinued oral intake through head and neck radiotherapy — user acceptance and content validation. Head Neck . 2020;42(9):2390 ‐ 2396. 84. Gonçalves Dias MC, de Fátima Nunes Marucci M, Nadalin W, Waitzberg DL. Nutritional intervention improves the caloric and proteic ingestion of head and neck cancer patients under radiotherapy. Nutr Hosp . 2005;20(5):320 ‐ 325. 85. Isenring EA, Bauer JD, Capra S. Nutrition support using the American Dietetic Association medical nutrition therapy protocol for radiation oncology patients improves dietary intake compared with standard practice. JAmDiet Assoc . 2007;107(3):404 ‐ 412. 86. Ravasco P, Monteiro ‐ Grillo I, Marques Vidal P, Camilo ME. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck . 2005;27(8):659 ‐ 668. 87. van den Berg MGA, Rasmussen ‐ Conrad EL, Wei KH, Lintz ‐ Luidens H, Kaanders JHAM, Merkx MAW. Comparison of the effect of individual dietary counselling and of standard nutritional care on weight loss in patients with head and neck cancer undergoing radiotherapy. Br J Nutr . 2010;104(6):872 ‐ 877. 88. P fi ster DG, Ang KK, Brizel DM, et al. Head and neck cancers, version 2.2013. J Natl Compr Canc Netw . 2013;11(8):917 ‐ 923. 89. Macfarlane TV, Wirth T, Ranasinghe S, Ah ‐ See KW, Renny N, Hurman D. Head and neck cancer pain: systematic review of prevalence and associated factors. J Oral Maxillofac Res . 2012;3(1):e1. 90. Jain PN, Chatterjee A, Choudhary AH, Sareen R. Prevalence, etiology, and management of neuropathic pain in an Indian cancer hospital. J Pain Palliat Care Pharmacother . 2009;23(2):114 ‐ 119. 91. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta ‐ analysis. Lancet Neurol . 2015;14(2):162 ‐ 173. 92. Smith DK, Cmelak A, Niermann K, et al. Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemor adiation. Head Neck . 2020;42(12):3497 ‐ 3505. 93. Yang W, McNutt TR, Dudley SA, et al. Predictive factors for prophylactic percutaneous endoscopic gastrostomy (PEG) tube placement and use in head and neck patients following intensity ‐ modulated radiation therapy (IMRT) treatment: concordance, discrepancies, and the role of gabapentin. Dysphagia . 2016;31(2):206 ‐ 213. 94. Starmer HM, Ayoub N, Byward C, et al. The impact of developing a speech and swallow rehab program: im proving patient satisfaction and multidisciplinary care. Laryngoscope . 2017;127(11):2578 ‐ 2581. 95. Sanders JG, Dawes PJD. Gabapentin for perioperative analgesia in otorhinolaryngology ‐ head and neck surgery:

systematic review.

Otolaryngol Head Neck Surg .

2016;155(6):893 ‐ 903. 96. Lee AW, Ngan RK, Tung SY, et al. Preliminary results of trial NPC ‐ 0501 evaluating the therapeutic gain by chan ging from concurrent ‐ adjuvant to induction ‐ concurrent chemoradiotherapy, changing from fl uorouracil to capeci tabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma. Cancer . 2015;121(8):1328 ‐ 1338. 97. Poon DMC, Kam MKM, Johnson D, Mo F, Tong M, Chan ATC. Durability of the parotid ‐ sparing effect of intensity ‐ modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: a 15 ‐ year follow ‐ up of a randomized prospective study of IMRT versus two ‐ dimensional radiotherapy. Head Neck . 2021;43(6):1711 ‐ 1720. 98. Gupta T, Sinha S, Ghosh ‐ Laskar S, et al. Intensity ‐ modulated radiation therapy versus three ‐ dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long ‐ term and mature outcomes of a prospec tive randomized trial. Radiat Oncol . 2020;15(1):218. 99. Al ‐ Mamgani A, Van Rooij P, Tans L, Teguh DN, Levendag PC. Toxicity and outcome of intensity ‐ modulated radiotherapy versus 3 ‐ dimensional conformal radiotherapy for oropharyngeal cancer: a matched ‐ pair analysis. Technol Cancer Res Treat . 2013;12(2):123 ‐ 130. 100. Kerr P, Myers CL, Butler J, Alessa M, Lambert P, Cooke AL. Prospective functional outcomes in sequential popula tion based cohorts of stage III/IV oropharyngeal carci noma patients treated with 3D conformal vs. intensity modulated radiotherapy. J Otolaryngol Head Neck Surg . 2015;44(1):17. 101. Christianen MEMC, Schilstra C, Beetz I, et al. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol . 2012;105(1):107 ‐ 114. 102. Ursino S, D'Angelo E, Mazzola R, et al. A comparison of swallowing dysfunction after three ‐ dimensional conformal and intensity ‐ modulated radiotherapy: a systematic review by the Italian Head and Neck Radiotherapy Study Group. Strahlenther Onkol . 2017;193(11):877 ‐ 889. 103. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head ‐ and ‐ neck cancer: which anatomic structures are affected and can they be spared by IMRT. Int J Radiat Oncol Biol Phys . 2004;60(5):1425 ‐ 1439. 104. Feng FY, Kim HM, Lyden TH, et al. Intensity ‐ modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol . 2010;28(16):2732 ‐ 2738. 105. Eisbruch A, Levendag PC, Feng FY, et al. Can IMRT or brachytherapy reduce dysphagia associated with chemor adiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys . 2007;69(2 suppl):S40 ‐ S42.